“depends on whether the FDA is recalcitrant abou
Post# of 148154
(Total Views: 457)
Posted On: 05/29/2022 2:43:54 PM
“depends on whether the FDA is recalcitrant about using mixed data.”
The FDA rules of the game on mixing data from different sources (and sample size requirements) were known long before Cytodyn dosed any of the patients. This isn’t the FDA being recalcitrant, it is Cytodyn not being smart and there have been a number of posters here saying so for quite a while.
Read More: https://investorshangout.com/post/view?id=641...z7UhgCSkSA
The FDA rules of the game on mixing data from different sources (and sample size requirements) were known long before Cytodyn dosed any of the patients. This isn’t the FDA being recalcitrant, it is Cytodyn not being smart and there have been a number of posters here saying so for quite a while.
Read More: https://investorshangout.com/post/view?id=641...z7UhgCSkSA
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼